BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10980812)

  • 1. Photodynamic therapy with verteporfin (Visudyne) for macular degeneration.
    Med Lett Drugs Ther; 2000 Sep; 42(1086):81-2. PubMed ID: 10980812
    [No Abstract]   [Full Text] [Related]  

  • 2. Can [symbol: see text] verteporfin help in macular degeneration?
    Drug Ther Bull; 2001 Apr; 39(4):30-2. PubMed ID: 11329798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodynamic therapy for age-related macular degeneration.
    Beck RW
    Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
    Sternberg P; Lewis H
    Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Photodynamic therapy and age-related macular degeneration in 2000].
    Desmettre T; Cohen SY; Mordon S
    J Fr Ophtalmol; 2001 Jan; 24(1):82-93. PubMed ID: 11240477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration].
    Augustin AJ
    Krankenpfl J; 2000 Oct; 38(9-10):342-3. PubMed ID: 11194354
    [No Abstract]   [Full Text] [Related]  

  • 8. Photodynamic therapy for age-related macular degeneration.
    Franks W
    Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement after verteporfin therapy.
    Anand R; Bressler NM; Bressler SB; Gray TE; Harvey P; Haynes L; Koester JM; Manos KS; Miller JW; Murphy S; Reaves A; Sickenberg M; Singerman LJ; Strong A; Stur M;
    Arch Ophthalmol; 2003 Mar; 121(3):415-6. PubMed ID: 12617718
    [No Abstract]   [Full Text] [Related]  

  • 10. Verteporfin ocular photodynamic therapy.
    Bakri SJ; Kaiser PK
    Expert Opin Pharmacother; 2004 Jan; 5(1):195-203. PubMed ID: 14680447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy in age-related macular degeneration: missing information.
    Wenkstern A; Stokes J
    Age Ageing; 2003 May; 32(3):357-9. PubMed ID: 12720631
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne).
    Mandal N; Chisholm IH
    Br J Ophthalmol; 2002 Jan; 86(1):118-9. PubMed ID: 11801521
    [No Abstract]   [Full Text] [Related]  

  • 13. Using light to treat age-related macular degeneration.
    Nosek J
    Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
    Harding S
    Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on photodynamic therapy in age-related macular degeneration.
    Rechtman E; Ciulla TA; Criswell MH; Pollack A; Harris A
    Expert Opin Pharmacother; 2002 Jul; 3(7):931-8. PubMed ID: 12083992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthaproblem. Photodynamic therapy with verteporfin.
    Sharma S
    Can Fam Physician; 2001 May; 47():955, 963. PubMed ID: 11398726
    [No Abstract]   [Full Text] [Related]  

  • 18. Model study of AREDS antioxidant supplementation of AMD compared to Visudyne: a dominant strategy?
    Trevithick J; Massel D; Robertson JM; Tomany S; Wall R
    Ophthalmic Epidemiol; 2004 Dec; 11(5):337-46. PubMed ID: 15590581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photodynamic therapy of age-related macular degeneration].
    Jaakkola A
    Duodecim; 2002; 118(8):813-9. PubMed ID: 12238196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.